WallStreetZenWallStreetZen

NASDAQ: IOVA
Iovance Biotherapeutics Inc Stock Ownership - Who owns Iovance Biotherapeutics?

OverviewForecastEarningsRevenueDividendOwnership

Insider buying vs selling

Have Iovance Biotherapeutics Inc insiders been buying or selling?
Buy
Sell
NameRoleDateSharesPriceValue
Jeanmarc BelleminChief Financial Officer2024-09-0311,891$10.85
$129.02kSell
Igor BilinskyChief Operating Officer2024-09-0311,891$10.85
$129.02kSell
Igor BilinskyChief Operating Officer2024-09-031,784$10.85
$19.36kSell
Finckenstein Friedrich GrafChief Medical Officer2024-09-0311,891$10.85
$129.02kSell
Finckenstein Friedrich GrafChief Medical Officer2024-09-031,983$10.85
$21.52kSell
Frederick G. VogtInterim CEO General Counsel2024-09-0319,913$10.85
$216.06kSell
Frederick G. VogtInterim CEO General Counsel2024-09-034,426$10.85
$48.02kSell
Igor BilinskyChief Operating Officer2024-07-151,428$8.68
$12.40kSell
Finckenstein Friedrich GrafChief Medical Officer2024-07-151,428$8.68
$12.40kSell
Frederick G. VogtInterim CEO General Counsel2024-07-158,851$8.68
$76.83kSell

1 of 3

IOVA insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when IOVA insiders and whales buy or sell their stock.

IOVA Shareholders

What type of owners hold Iovance Biotherapeutics Inc stock?
Institutional
Insider
Retail
NameHoldSharesValueType
Ayer Capital Management LP185.57%563,224,483$5.49BInsider
Paul L. Kessler136.92%415,566,430$4.05BInsider
Wayne P. Rothbaum9.25%28,067,333$273.38MInsider
Vanguard Group Inc8.55%25,950,644$252.76MInstitution
Perceptive Advisors LLC8.54%25,933,142$252.59MInstitution
Mhr Fund Management LLC7.91%23,997,103$233.73MInstitution
Blackrock Inc6.99%21,225,119$206.73MInstitution
Atlantic Hamilton6.91%20,960,016$204.15MInsider
David J. Voyticky6.25%18,981,082$184.88MInsider
Sanford Hillsberg4.45%13,500,000$131.49MInsider

1 of 3

IOVA vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
IOVA17.67%82.33%Net BuyingNet Selling
EWTX87.20%12.80%Net BuyingNet Selling
PTCT85.02%14.98%Net SellingNet Selling
RYTM88.36%11.64%Net SellingNet Selling
KYMR77.96%22.04%Net SellingNet Buying
View Top Biotech Stocks

Iovance Biotherapeutics Stock Ownership FAQ

Who owns Iovance Biotherapeutics?

Iovance Biotherapeutics (NASDAQ: IOVA) is owned by 76.60% institutional shareholders, 356.95% Iovance Biotherapeutics insiders, and 0.00% retail investors. Ayer Capital Management LP is the largest individual Iovance Biotherapeutics shareholder, owning 563.22M shares representing 185.57% of the company. Ayer Capital Management LP's Iovance Biotherapeutics shares are currently valued at $5.50B.

If you're new to stock investing, here's how to buy Iovance Biotherapeutics stock.
©2024 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.